Patent · US Active

Formulation for oral transmucosal administration of lipid-lowering drugs

US8889663B2 · kind B2 · utility

1Cited by
1References
6Claims
0Family size

Inventors

Key dates

Filing dateDec 17, 2009
Grant dateNov 18, 2014
Priority date—
Expiry dateJan 12, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a formulation for delivering by oral transmucosal administration at least one lipid-lowering active principle, preferably from the statin family, said formulation including said active principle in the base or salt form, an aqueous alcohol solution titrating at least 30° alcohol, and optionally a pH correcting agent and/or an antioxidant, said active principle being in a stable and completely dissolved state in the aqueous alcohol solution. The invention also relates to a method of preparing said formulation and to the use thereof, preferably in single-dose packaging, for treating and preventing hyperlipemia and/or cardiovascular conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.